0001209191-12-016968.txt : 20120308 0001209191-12-016968.hdr.sgml : 20120308 20120308185640 ACCESSION NUMBER: 0001209191-12-016968 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120301 FILED AS OF DATE: 20120308 DATE AS OF CHANGE: 20120308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DRISCOLL FREDERICK W CENTRAL INDEX KEY: 0001129890 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26770 FILM NUMBER: 12678584 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NOVAVAX INC CENTRAL INDEX KEY: 0001000694 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222816046 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9920 BELWARD CAMPUS DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 240-268-2000 MAIL ADDRESS: STREET 1: 9920 BELWARD CAMPUS DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 4 1 doc4.xml FORM 4 SUBMISSION X0304 4 2012-03-01 0 0001000694 NOVAVAX INC NVAX 0001129890 DRISCOLL FREDERICK W 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850 0 1 0 0 VP, CFO & Treasurer Options-right to buy 1.28 2012-03-01 4 A 0 150000 1.28 A 2022-03-01 Common Stock 150000 580000 D Options shall vest in four equal annual installments beginning on the first anniversary of the date of grant. /s/ John Herrmann, Attorney-in-fact for Frederick W. Driscoll 2012-03-08